Compare ProShares Ultra QQQ ETF (QLD) vs Select Medical Holdings Corporation (SEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ProShares Ultra QQQ ETF vs Select Medical Holdings Corporation — how do they compare? ProShares Ultra QQQ ETF trades at $88.16, while Select Medical Holdings Corporation trades at $16.51 (market cap $2.05B). The key difference: Select Medical Holdings Corporation pays a 1.51% dividend while ProShares Ultra QQQ ETF pays none, and Select Medical Holdings Corporation is trading nearer its 52-week high, ProShares Ultra QQQ ETF nearer its low. Which is the better fit depends on your goals.
| QLD | SEM | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $100.53 | $16.66 |
52-Week Low | $57.16 | $11.77 |
Market Cap | — | $2.05B |
Enterprise Value | — | $5.01B |
Dividend Yield | — | 1.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QLD, the ProShares Ultra QQQ ETF, trades at $86.06, up 0.17% on the day, with a bearish technical signal driven by moving averages. The ETF, which provides 2x daily leveraged exposure to the Nasdaq-100 index, has delivered over 10,000% total return since inception, demonstrating powerful long-term compounding. Recent news highlights its role in tech-focused strategies amid a Nasdaq comeback, though leveraged structure amplifies volatility.
Outlook is mixed: technicals suggest near-term caution, but long-term growth potential remains tied to tech sector performance. Key risks include daily rebalancing effects in volatile markets and significant drawdowns, as seen historically. Investors should weigh leveraged benefits against inherent volatility and holding period considerations.
Select Medical (SEM) trades at $16.51, unchanged on the day, amid a completed acquisition by a consortium led by Robert A. Ortenzio and Martin F. at $16.50 per share. The stock shows a bullish technical signal with support and resistance clustered around $17. Financially, the company reported 2025 revenue of $5.45B and net income of $146.22M, with a P/E of 15.43 and P/S of 0.36 indicating moderate valuation. Recent earnings have been mixed, with a beat in Q3 2025 but misses in Q4 2025 and Q1 2026.
The acquisition at $16.50 per share caps near-term upside, with legal investigations into the board's fiduciary duties posing a key risk. Analyst sentiment is mixed with 35.71% buy ratings but 57.15% hold, reflecting uncertainty post-buyout. Investors should note the stock's limited movement potential given the acquisition price, with fundamental performance and legal outcomes driving any residual value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ProShares Ultra QQQ ETF
QLD is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the NASDAQ-100 Index. It achieves 2x leverage by investing in financial instruments such as swaps and is designed as a tactical trading tool for investors with a bullish (long) view on the NASDAQ-100. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on QLD →About Select Medical Holdings Corporation
Select Medical Holdings Corporation is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's services focus on treating patients with serious illnesses, injuries, and post-acute care needs. SEM provides specialized care across various settings, aiming to help patients recover and return home.
Read more on SEM →
